Agency Forms Undergoing Paperwork Reduction Act Review, 78156-78158 [2016-26829]
Download as PDF
78156
Federal Register / Vol. 81, No. 215 / Monday, November 7, 2016 / Notices
NHANES plans to conduct a blood
pressure methodology study. The study
population will be NHANES
participants aged 6 and older who agree
to come to the Mobile Examination
Center (MEC).
The bio-specimens collected for
laboratory analytes include urine, blood,
vaginal and penile swabs, and
household water collection. Serum,
plasma and urine specimens are stored
for future testing, including genetic
research, if the participant consents.
NHANES 2017–18 plans to add the
following lab tests: Three Phthalates in
urine (ages 3+); nine urinary flame
retardants in urine (ages 3+); one insect
repellant in urine (ages 3+); one volatile
organic compound (VOC) metabolite in
urine (ages 3+); eighteen tobacco
biomarkers in urine (ages 3+); two
metals in urine (ages 3+); vitamin C in
serum (ages 6+); vitamins A, E, and
carotenoids in serum (ages 6+);
Unsaturated Iron Binding Capacity
(UIBC)/Total Iron Binding Capacity
(TIBC) in serum (ages 12+); congenital
cytomegalovirus (CMV) in sera (ages 1–
5); and a test in urine for Mycoplasm
genitalium (ages 14–59).
In addition metals in whole blood are
changing from a one-half sample to a
full sample (ages 1+). Polycyclic
Aromatic Hydrocarbons (PAHs) are
being discontinued in the smoker
oversample subgroup, however testing
will continue in a 1⁄3 subsample of
general NHANES participants.
The 2017–18 survey will also bring
back the Flexible Consumer Behavior
Survey Phone follow-Up questionnaire
for participant ages 1+. This takes place
in the home after the second dietary
recall is completed.
The following major examination or
laboratory items, that had been included
in the 2015–2016 NHANES, were cycled
out for NHANES 2017–2018: Pubertal
maturation, Oral Glucose Tolerance Test
(OGTT), oral Human Papilloma Virus
(HPV) rinse, Sagittal Abdominal
Diameter (SAD), dental fluorosis
assessment, dental fluorosis imaging
(DFI), plasma, urine and water fluoride,
Apo B analysis, three metals in serum
and three hormones and binding
proteins.
Most sections of the NHANES
interviews provide self-reported
information to be used either in concert
with specific examination or laboratory
content, as independent prevalence
estimates, or as covariates in statistical
analysis (e.g., socio-demographic
characteristics). Some examples include
alcohol, drug, and tobacco use, sexual
behavior, prescription and aspirin use,
and indicators of oral, bone,
reproductive, and mental health.
Several interview components support
the nutrition monitoring objective of
NHANES, including questions about
food security and nutrition program
participation, dietary supplement use,
and weight history/self-image/related
behavior.
In 2017–2018, we also plan to
implement electronic consent
procedures in NHANES. The consent for
birth certificate linkage that had been
included in previous NHANES will be
dropped from NHANES 2017–2018. The
survey may conduct a Vaccination
Providers’ Records Check project with
an emphasis on Human Papilloma Virus
(HPV), an Ambulatory Blood Pressure
Methodology (ABPM) study, test
questions related to Chronic Kidney
Disease (CKD), adopt digital imaging
technology to enhance the existing
collection of dietary supplement
information, implement multi-mode
screening, conduct specimen collection
for liver-related DNA markers, and cycle
back in consent to store DNA, if
resources permit, in the current or in a
future cycle of NHANES.
There is no cost to respondents other
than their time. Total burden hours
requested is 79,894.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondent
Form name
Individuals in households ......
Individuals in households ......
NHANES Questionnaire ...............................
Blood Pressure Methodology Study Phase
1.
Blood Pressure Methodology Study Phase
2.
Flexible Consumer Behavior Survey Phone
Follow-Up.
Developmental Projects & Special Studies
Wearable Device Projects ............................
Individuals in households ......
Individuals in households ......
Individuals in households ......
Individuals in households ......
2.5
30/60
36,025
702
2000
1
30/60
1000
5,000
1
20/60
1,667
3,500
1,200
1
1
3
25
10,500
30,000
[FR Doc. 2016–26831 Filed 11–4–16; 8:45 am]
[30Day–17–16BBS]
sradovich on DSK3GMQ082PROD with NOTICES
Centers for Disease Control and
Prevention
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
16:02 Nov 04, 2016
Jkt 241001
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
Total burden
hours
1
1
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
VerDate Sep<11>2014
Average
burden per
response
(in hours)
14,410
1,404
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
BILLING CODE 4163–18–P
Number of
responses per
respondent
the proposed information collection is
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
burden of the proposed collection of
information, including the validity of
E:\FR\FM\07NON1.SGM
07NON1
78157
Federal Register / Vol. 81, No. 215 / Monday, November 7, 2016 / Notices
the methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Written
comments and/or suggestions regarding
the items contained in this notice
should be directed to the Attention:
CDC Desk Officer, Office of Management
and Budget, Washington, DC 20503 or
by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Proposed Project
Airline and Traveler Information
Collection: Domestic Manifests and the
Passenger Locator Form—Existing
Information Collection in use without
an OMB Control Number—National
Center for Emerging Zoonotic and
Infectious Diseases (NCEZID), Centers
for Disease Control and Prevention
(CDC).
Background and Brief Description
Stopping a communicable disease
outbreak—whether it is naturally
occurring or intentionally caused—
requires the use of the most rapid and
effective public health tools available.
Basic public health practices, such as
collaborating with airlines in the
identification and notification of
potentially exposed contacts, are critical
tools in the fight against the
introduction, transmission, and spread
of communicable diseases in the United
States.
The collection of timely, accurate, and
complete contact information enables
Quarantine Public Health Officers in
CDC’s Division of Global Migration and
Quarantine (DGMQ) to notify state and
local health departments in order for
them to make contact with individuals
who may have been exposed to a
contagious person during travel and
identify appropriate next steps.
Under the Public Health Service Act
(42 United States Code 264) and under
42 Code of Federal Regulations (CFR)
70.2 CDC can order airlines traveling
between states to submit a data set,
including airline flight details, and
passenger and crew member
information, if CDC reasonably believes
that a traveler exposed to or infected
with a communicable disease of public
health concern could have put other
passengers at risk for a communicable
disease.
In order to collect this data set, aka a
manifest, CDC seeking approval for
domestic airline and traveler
information orders under current
authorities in 42 Code of Federal
Regulations (CFR) 70.2. This activity is
already current practice.
Additionally, CDC requests to
transition the Passenger Locator Form
(PLF), previously included and
approved by OMB in 0920–0134 Foreign
Quarantine Regulations, into this
Information Collection Request. Further,
CDC is requesting approval for the use
of the PLF for the collection of traveler
information from individuals on
domestic flights. The PLF, a formed
developed by the International Civil
Aviation Organization (ICAO) in concert
with its international member states and
other aviation organizations, is used
when there is a confirmation or strong
suspicion that an individual(s) aboard a
flight is infected with or exposed to a
communicable disease that is a threat to
co-travelers, and CDC is made aware of
the individual(s) prior to arrival in the
United States. This prior awareness can
provide CDC with an opportunity to
collect traveler contact information
directly from the traveler prior to
departure from the arrival airport. CDC
conducts this information collection
under its regulations at 42 CFR 70.6 for
domestic flights and 71.32 and 71.33 for
flights arriving from foreign countries.
CDC seeks a three-year OMB
clearance for this information collection
request.
Estimated Annualized Burden Hours
CDC estimates that for each set of
airline and traveler information ordered,
airlines require approximately six hours
to review the order, search their records,
and send those records to CDC. CDC
anticipates that travelers will need
approximately five minutes to complete
the PLF. There is no cost to respondents
other than their time to perform these
actions. For manifest information, CDC
does not have a specified format for
these submissions, only that it is one
acceptable to both CDC and the
respondent.
Number of
responses per
respondent
Number of
respondents
Average
burden per
response
(in hours)
Type of respondent
Form name
Airline Medical Officer or Equivalent/Computer and Information Systems Manager.
Airline Medical Officer or Equivalent/Computer and Information Systems Manager.
Traveler ...........................................................
Domestic TB Manifest Template ....................
1
1
360/60
Domestic Non-TB Manifest Template ............
28
1
360/60
Public Health Passenger Locator Form: Outbreak of public health significance (international flights).
Public Health Passenger Locator Form: Limited onboard exposure (international flights.
Public Health Passenger Locator Form (domestic flights).
2,700,000
1
5/60
800
1
5/60
800
1
5/60
.........................................................................
........................
........................
........................
Traveler ...........................................................
Traveler ...........................................................
sradovich on DSK3GMQ082PROD with NOTICES
Total .........................................................
VerDate Sep<11>2014
16:02 Nov 04, 2016
Jkt 241001
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
E:\FR\FM\07NON1.SGM
07NON1
78158
Federal Register / Vol. 81, No. 215 / Monday, November 7, 2016 / Notices
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2016–26829 Filed 11–4–16; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Written
comments and/or suggestions regarding
the items contained in this notice
should be directed to the Attention:
CDC Desk Officer, Office of Management
and Budget, Washington, DC 20503 or
by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Proposed Project
[30Day–17–0612]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
Well-Integrated Screening and
Evaluation for Women Across the
Nation (WISEWOMAN) Reporting
System (OMB #0920–0612, exp. 12/31/
2016)—Extension—National Center for
Chronic Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The WISEWOMAN program (WellIntegrated Screening and Evaluation for
Women Across the Nation), sponsored
by the Centers for Disease Control and
Prevention (CDC), was established to
examine ways to improve the delivery
of services for women who have limited
access to health care and elevated risk
factors for cardiovascular disease (CVD).
The program focuses on reducing CVD
risk factors and provides screening
services for selected risk factors such as
elevated blood cholesterol,
hypertension, and abnormal blood
glucose levels. The program also
provides women with referrals to
lifestyle programs and medical care. The
WISEWOMAN program provides
services to women who are jointly
enrolled in the National Breast and
Cervical Cancer Early Detection Program
(NBCCEDP), also administered by CDC.
The WISEWOMAN program is
administered by state health
departments and tribal programs. In
2013, new cooperative agreements were
awarded under Funding Opportunity
Announcement DP13–1302. These
awards are currently in the final year of
funding, but may be extended by CDC
for one additional year, subject to the
availability of funds.
CDC collects two types of information
from WISEWOMAN awardees. The
hardcopy Annual Progress Report
provides a narrative summary of each
awardee’s objectives and the activities
undertaken to meet program goals. The
estimated burden per response is 16
hours.
In addition, each WISEWOMAN
awardee submits an electronic data file
to CDC twice per year. The Minimum
Data Elements (MDE) file contains deidentified, client-level information
about the cardiovascular disease risk
factors of women served by the program,
and the number and type of lifestyle
program sessions they attend. The
estimated burden per response for the
MDE file is 24 hours.
CDC seeks a one-year extension to
enable reporting for the final year of
activities funded under the current
cooperative agreement and the option
year, subject to the availability of funds.
There are no changes to the information
collected, the burden per response,
reporting frequency, the number of
awardees, or the total annualized
burden hours.
CDC will continue to use the
information collected from
WISEWOMAN awardees to support
program monitoring and improvement
activities, evaluation, and assessment of
program outcomes. The overall program
evaluation is designed to demonstrate
how WISEWOMAN can obtain more
complete health data on vulnerable
populations, promote public education
about disease incidence, cardiovascular
disease risk-factors, health promotion,
improve the availability of screening
and diagnostic services for under-served
women, ensure the quality of services
provided to underserved women, and
develop strategies for improved
interventions. Participation in this
information collection is required as a
condition of cooperative agreement
funding. There are no costs to
respondents other than their time.
The total annualized burden hours are
1,344.
sradovich on DSK3GMQ082PROD with NOTICES
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondents
Form name
WISEWOMAN Awardees ................................
Screening and Assessment and Lifestyle
Program MDEs.
Annual Progress Report .................................
VerDate Sep<11>2014
16:02 Nov 04, 2016
Jkt 241001
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
E:\FR\FM\07NON1.SGM
Number of
responses per
respondent
Average
burden per
response
(in hrs.)
21
2
24
21
1
16
07NON1
Agencies
[Federal Register Volume 81, Number 215 (Monday, November 7, 2016)]
[Notices]
[Pages 78156-78158]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-26829]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-17-16BBS]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) has submitted
the following information collection request to the Office of
Management and Budget (OMB) for review and approval in accordance with
the Paperwork Reduction Act of 1995. The notice for the proposed
information collection is published to obtain comments from the public
and affected agencies.
Written comments and suggestions from the public and affected
agencies concerning the proposed collection of information are
encouraged. Your comments should address any of the following: (a)
Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility; (b) Evaluate the
accuracy of the agencies estimate of the burden of the proposed
collection of information, including the validity of
[[Page 78157]]
the methodology and assumptions used; (c) Enhance the quality, utility,
and clarity of the information to be collected; (d) Minimize the burden
of the collection of information on those who are to respond, including
through the use of appropriate automated, electronic, mechanical, or
other technological collection techniques or other forms of information
technology, e.g., permitting electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to omb@cdc.gov. Written comments and/or
suggestions regarding the items contained in this notice should be
directed to the Attention: CDC Desk Officer, Office of Management and
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written
comments should be received within 30 days of this notice.
Proposed Project
Airline and Traveler Information Collection: Domestic Manifests and
the Passenger Locator Form--Existing Information Collection in use
without an OMB Control Number--National Center for Emerging Zoonotic
and Infectious Diseases (NCEZID), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Stopping a communicable disease outbreak--whether it is naturally
occurring or intentionally caused--requires the use of the most rapid
and effective public health tools available. Basic public health
practices, such as collaborating with airlines in the identification
and notification of potentially exposed contacts, are critical tools in
the fight against the introduction, transmission, and spread of
communicable diseases in the United States.
The collection of timely, accurate, and complete contact
information enables Quarantine Public Health Officers in CDC's Division
of Global Migration and Quarantine (DGMQ) to notify state and local
health departments in order for them to make contact with individuals
who may have been exposed to a contagious person during travel and
identify appropriate next steps.
Under the Public Health Service Act (42 United States Code 264) and
under 42 Code of Federal Regulations (CFR) 70.2 CDC can order airlines
traveling between states to submit a data set, including airline flight
details, and passenger and crew member information, if CDC reasonably
believes that a traveler exposed to or infected with a communicable
disease of public health concern could have put other passengers at
risk for a communicable disease.
In order to collect this data set, aka a manifest, CDC seeking
approval for domestic airline and traveler information orders under
current authorities in 42 Code of Federal Regulations (CFR) 70.2. This
activity is already current practice.
Additionally, CDC requests to transition the Passenger Locator Form
(PLF), previously included and approved by OMB in 0920-0134 Foreign
Quarantine Regulations, into this Information Collection Request.
Further, CDC is requesting approval for the use of the PLF for the
collection of traveler information from individuals on domestic
flights. The PLF, a formed developed by the International Civil
Aviation Organization (ICAO) in concert with its international member
states and other aviation organizations, is used when there is a
confirmation or strong suspicion that an individual(s) aboard a flight
is infected with or exposed to a communicable disease that is a threat
to co-travelers, and CDC is made aware of the individual(s) prior to
arrival in the United States. This prior awareness can provide CDC with
an opportunity to collect traveler contact information directly from
the traveler prior to departure from the arrival airport. CDC conducts
this information collection under its regulations at 42 CFR 70.6 for
domestic flights and 71.32 and 71.33 for flights arriving from foreign
countries.
CDC seeks a three-year OMB clearance for this information
collection request.
Estimated Annualized Burden Hours
CDC estimates that for each set of airline and traveler information
ordered, airlines require approximately six hours to review the order,
search their records, and send those records to CDC. CDC anticipates
that travelers will need approximately five minutes to complete the
PLF. There is no cost to respondents other than their time to perform
these actions. For manifest information, CDC does not have a specified
format for these submissions, only that it is one acceptable to both
CDC and the respondent.
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Type of respondent Form name respondents responses per response (in
respondent hours)
----------------------------------------------------------------------------------------------------------------
Airline Medical Officer or Equivalent/ Domestic TB Manifest 1 1 360/60
Computer and Information Systems Template.
Manager.
Airline Medical Officer or Equivalent/ Domestic Non-TB Manifest 28 1 360/60
Computer and Information Systems Template.
Manager.
Traveler.............................. Public Health Passenger 2,700,000 1 5/60
Locator Form: Outbreak
of public health
significance
(international flights).
Traveler.............................. Public Health Passenger 800 1 5/60
Locator Form: Limited
onboard exposure
(international flights.
Traveler.............................. Public Health Passenger 800 1 5/60
Locator Form (domestic
flights).
-----------------------------------------------
Total............................. ........................ .............. .............. ..............
----------------------------------------------------------------------------------------------------------------
[[Page 78158]]
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2016-26829 Filed 11-4-16; 8:45 am]
BILLING CODE 4163-18-P